Clinical Study on Continuous Suture of Endoscopic Mucosal Defects
Primary Purpose
Colonic Polyp, Gastrointestinal Neoplasms
Status
Recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Cotinuous suture
Clips
Sponsored by
About this trial
This is an interventional treatment trial for Colonic Polyp focused on measuring Endoscopic mucosal resection, Endoscopic submucosal dissection, Gastrolintestinal polyps, Continuous suture, Clips
Eligibility Criteria
Inclusion Criteria:
- The indications for endoscopic resection were large (≥20mm in diameter), nonpedunculated, benign, and early malignant mucosal or submucosal gastric or colorectal lesions.
- Written informed consent
Exclusion Criteria:
- The tumor has spread to the muscularis layer, lymph nodes, or distal metastases;
- Multiple lesions (≥20mm in diameter) ;
- Underlying bleeding disorder;
- The platelet count less than 50×10^9/L;
- Serious cardio-pulmonary, hepatic or renal disease;
- Intolerance to endoscopy;
- Other high-risk conditions or disease (such as massive ascites, etc.);
- Pregnancy.
Sites / Locations
- The Fifth Medical Center of Chinese PLA General HosptialRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Continuous suture group
Clips group
Arm Description
Surgical sutures were used to completely close the post-EMR/ESD mucosal/submucosal defects. This group was set as a experimental group.
Clips were used to completely close the post-EMR/ESD mucosal/submucosal defects. This group was set as a control group.
Outcomes
Primary Outcome Measures
The rates of complete closure of mucosal/submucosal defects
When the clips were applied next to each other and there were no substantial submucosal areas in the closure line
Secondary Outcome Measures
The duration time of closure
The duration of closure was defined as the interval from insertion of the first clip until complete or incomplete closure
The closure speed
The closure speed was defined as the resection area divided by 10x the duration of the ligation procedure (cm2 /10 minutes).
Immediate bleeding
Immediate bleeding refers to those episodes of hemorrhage that occurred during the procedure and lasted more than 30 seconds or required endoscopic treatment.
Delayed bleeding
Delayed bleeding was defined as bleeding requiring emergency endoscopic hemostasis or transfusion or the presence of hemoglobin loss≥2 g/dL after EMR/ESD
Delayed perforation
Delayed perforation was defined as the presence of free air on abdominal CT or radiography after completion of the procedure in patients without perforation during EMR/ESD and no symptoms of peritoneal irritation after EMR/ESD
Post polypectomy syndrome
Post polypectomy syndrome was defined by symptoms of pain, fever, leukocytosis, peritoneal tenderness, and guarding.
Full Information
NCT ID
NCT05190042
First Posted
November 23, 2021
Last Updated
February 24, 2022
Sponsor
Affiliated Hospital to Academy of Military Medical Sciences
1. Study Identification
Unique Protocol Identification Number
NCT05190042
Brief Title
Clinical Study on Continuous Suture of Endoscopic Mucosal Defects
Official Title
Clinical Study on Continuous Suture of Mucosal Defects After Endoscopic Mucosal Lesion Resection
Study Type
Interventional
2. Study Status
Record Verification Date
January 2022
Overall Recruitment Status
Recruiting
Study Start Date
January 18, 2022 (Actual)
Primary Completion Date
June 30, 2022 (Anticipated)
Study Completion Date
July 30, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Affiliated Hospital to Academy of Military Medical Sciences
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The use of clips to completely clip mucosal defects after ESD/EMR can reduce postoperative adverse events, but the rate of incomplete mucosal defects closure is high. The continuous suture technique can completely close the mucosal defects by using surgical sutures and clips to suture the mucosal defects after ESD/EMR. In this study, a clinical randomized controlled study was conducted in our hospital. A total of 62 enrolled patients were divided into two groups, 31 patients were set as a treatment group using continuous suture technique to close post-EMR/ESD mucosal/submucosal defects, the rest patients were set as a control group using clips. The safety and effectiveness of continuous sutures and clips to clamp the post-EMR/ESD mucosal/submucosal defect were compared in the two groups. The complete mucosal/submucosa defects closure rates were the primary outcome.
Detailed Description
Endoscopic submucosal resection (EMR) or submucosal dissection (ESD) for gastrointestinal lesions were used to treat early gastrointestinal cancer or large benign polyps, and their complete resection rates were high, which greatly reduce unnecessary surgical operations. However, after endoscopic resection of mucosal/submucosal lesions, large mucosal/submucosal defects may be created. These defects may cause more delayed postoperative adverse events (bleeding, perforation). The use of clips to completely seal the mucosal defect after gastrointestinal mucosal/submucosal lesion resection can significantly reduce postoperative adverse events, but the rate of incomplete mucosal defects closure is high. The surgical sutures combined with clips to close the mucosal defect after surgery significantly increased the complete closure rates of the post-EMR/ESD mucosal/submucosal defect. This study intends to further determine its safety and effectiveness through a clinical randomized controlled study, and standardize indications and contraindications. A total of 62 enrolled patients were allocated into two groups, 31 patients were set as a treatment group using continuous suture technique to close post-EMR/ESD mucosal/submucosal defects, the rest patients were set as a control group using clips. The safety and effectiveness of continuous sutures and clips to clamp the post-EMR/ESD mucosal/submucosal defect were compared in the two groups. The primary outcome was complete mucosal/submucosa defects closure rates. The secondary outcomes were the closure time, closure speed, and immediate bleeding during the operation as well as delayed bleeding, delayed perforation, and polyps syndrome after resection.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colonic Polyp, Gastrointestinal Neoplasms
Keywords
Endoscopic mucosal resection, Endoscopic submucosal dissection, Gastrolintestinal polyps, Continuous suture, Clips
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Masking Description
This was a single-blind study where patients were not informed about their randomization allocation.
Allocation
Randomized
Enrollment
62 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Continuous suture group
Arm Type
Experimental
Arm Description
Surgical sutures were used to completely close the post-EMR/ESD mucosal/submucosal defects.
This group was set as a experimental group.
Arm Title
Clips group
Arm Type
Active Comparator
Arm Description
Clips were used to completely close the post-EMR/ESD mucosal/submucosal defects. This group was set as a control group.
Intervention Type
Device
Intervention Name(s)
Cotinuous suture
Intervention Description
Cotinuous suture using surgery thread
Intervention Type
Device
Intervention Name(s)
Clips
Intervention Description
Hemostatic clips
Primary Outcome Measure Information:
Title
The rates of complete closure of mucosal/submucosal defects
Description
When the clips were applied next to each other and there were no substantial submucosal areas in the closure line
Time Frame
1day
Secondary Outcome Measure Information:
Title
The duration time of closure
Description
The duration of closure was defined as the interval from insertion of the first clip until complete or incomplete closure
Time Frame
1 day
Title
The closure speed
Description
The closure speed was defined as the resection area divided by 10x the duration of the ligation procedure (cm2 /10 minutes).
Time Frame
1day
Title
Immediate bleeding
Description
Immediate bleeding refers to those episodes of hemorrhage that occurred during the procedure and lasted more than 30 seconds or required endoscopic treatment.
Time Frame
1 day
Title
Delayed bleeding
Description
Delayed bleeding was defined as bleeding requiring emergency endoscopic hemostasis or transfusion or the presence of hemoglobin loss≥2 g/dL after EMR/ESD
Time Frame
14 days
Title
Delayed perforation
Description
Delayed perforation was defined as the presence of free air on abdominal CT or radiography after completion of the procedure in patients without perforation during EMR/ESD and no symptoms of peritoneal irritation after EMR/ESD
Time Frame
14 days
Title
Post polypectomy syndrome
Description
Post polypectomy syndrome was defined by symptoms of pain, fever, leukocytosis, peritoneal tenderness, and guarding.
Time Frame
14 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
The indications for endoscopic resection were large (≥20mm in diameter), nonpedunculated, benign, and early malignant mucosal or submucosal gastric or colorectal lesions.
Written informed consent
Exclusion Criteria:
The tumor has spread to the muscularis layer, lymph nodes, or distal metastases;
Multiple lesions (≥20mm in diameter) ;
Underlying bleeding disorder;
The platelet count less than 50×10^9/L;
Serious cardio-pulmonary, hepatic or renal disease;
Intolerance to endoscopy;
Other high-risk conditions or disease (such as massive ascites, etc.);
Pregnancy.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yan Liu, MD
Phone
13911798288
Email
13911798288@163.com
First Name & Middle Initial & Last Name or Official Title & Degree
Jin Dong Chu, MD
Phone
15811201126
Email
chu465292278@163.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yan Liu, MD
Organizational Affiliation
Beijing 302 Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Fifth Medical Center of Chinese PLA General Hosptial
City
Beijing
State/Province
Beijing
ZIP/Postal Code
100039
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yan Liu, MD
Phone
+8613911798288
Email
13911798288@163.com
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Clinical Study on Continuous Suture of Endoscopic Mucosal Defects
We'll reach out to this number within 24 hrs